WO2019116329A1 - Use of maltodextrin for enhancing or improving cognition and/or stimulating brain development - Google Patents
Use of maltodextrin for enhancing or improving cognition and/or stimulating brain development Download PDFInfo
- Publication number
- WO2019116329A1 WO2019116329A1 PCT/IB2018/060083 IB2018060083W WO2019116329A1 WO 2019116329 A1 WO2019116329 A1 WO 2019116329A1 IB 2018060083 W IB2018060083 W IB 2018060083W WO 2019116329 A1 WO2019116329 A1 WO 2019116329A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- maltodextrin
- piglets
- formula
- memory
- cognitive
- Prior art date
Links
- 229920002774 Maltodextrin Polymers 0.000 title claims abstract description 67
- 239000005913 Maltodextrin Substances 0.000 title claims abstract description 49
- 229940035034 maltodextrin Drugs 0.000 title claims abstract description 49
- 230000004641 brain development Effects 0.000 title claims abstract description 16
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 8
- 230000004936 stimulating effect Effects 0.000 title claims abstract description 8
- 230000019771 cognition Effects 0.000 title claims description 25
- 241000124008 Mammalia Species 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 230000003931 cognitive performance Effects 0.000 claims abstract description 6
- 235000013350 formula milk Nutrition 0.000 claims description 84
- 230000015654 memory Effects 0.000 claims description 18
- 230000001149 cognitive effect Effects 0.000 claims description 16
- 229920002245 Dextrose equivalent Polymers 0.000 claims description 12
- 238000011161 development Methods 0.000 claims description 12
- 230000018109 developmental process Effects 0.000 claims description 12
- 230000007787 long-term memory Effects 0.000 claims description 11
- 210000004556 brain Anatomy 0.000 claims description 8
- 210000001320 hippocampus Anatomy 0.000 claims description 7
- 235000018102 proteins Nutrition 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 235000021120 animal protein Nutrition 0.000 claims description 3
- 235000020209 toddler milk formula Nutrition 0.000 claims description 3
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 abstract description 28
- 235000014633 carbohydrates Nutrition 0.000 abstract description 28
- 235000021125 infant nutrition Nutrition 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 38
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 32
- 239000000243 solution Substances 0.000 description 31
- 230000000694 effects Effects 0.000 description 28
- 239000008101 lactose Substances 0.000 description 27
- 230000003936 working memory Effects 0.000 description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- 235000016709 nutrition Nutrition 0.000 description 14
- 239000008103 glucose Substances 0.000 description 13
- 230000006872 improvement Effects 0.000 description 13
- 238000000926 separation method Methods 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000008267 milk Substances 0.000 description 12
- 210000004080 milk Anatomy 0.000 description 12
- 230000012010 growth Effects 0.000 description 11
- 235000013336 milk Nutrition 0.000 description 11
- 230000007704 transition Effects 0.000 description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 229930006000 Sucrose Natural products 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 239000005720 sucrose Substances 0.000 description 9
- 239000004376 Sucralose Substances 0.000 description 8
- 235000021196 dietary intervention Nutrition 0.000 description 8
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 8
- 235000019408 sucralose Nutrition 0.000 description 8
- 241000282887 Suidae Species 0.000 description 7
- 235000019219 chocolate Nutrition 0.000 description 7
- 206010052804 Drug tolerance Diseases 0.000 description 6
- 241000282412 Homo Species 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 6
- 240000006365 Vitis vinifera Species 0.000 description 6
- 235000014787 Vitis vinifera Nutrition 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 230000003920 cognitive function Effects 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 230000026781 habituation Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 241000282898 Sus scrofa Species 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000002641 glycemic effect Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000003542 behavioural effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 235000021050 feed intake Nutrition 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000006403 short-term memory Effects 0.000 description 4
- 230000004075 alteration Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000003925 brain function Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000013016 learning Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 210000002442 prefrontal cortex Anatomy 0.000 description 3
- 230000003938 response to stress Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 235000021490 Caloric beverage Nutrition 0.000 description 2
- 240000000491 Corchorus aestuans Species 0.000 description 2
- 235000011777 Corchorus aestuans Nutrition 0.000 description 2
- 235000010862 Corchorus capsularis Nutrition 0.000 description 2
- 235000019755 Starter Diet Nutrition 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000037185 brain physiology Effects 0.000 description 2
- 235000021074 carbohydrate intake Nutrition 0.000 description 2
- 230000003930 cognitive ability Effects 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000009699 differential effect Effects 0.000 description 2
- 235000020218 follow-on milk formula Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000020803 food preference Nutrition 0.000 description 2
- 230000004153 glucose metabolism Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000000971 hippocampal effect Effects 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 208000018773 low birth weight Diseases 0.000 description 2
- 231100000533 low birth weight Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 235000006180 nutrition needs Nutrition 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000006886 spatial memory Effects 0.000 description 2
- 239000006054 starter diet Substances 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 1
- 241000282979 Alces alces Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000282470 Canis latrans Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000282330 Procyon lotor Species 0.000 description 1
- 241000282374 Puma concolor Species 0.000 description 1
- 238000011869 Shapiro-Wilk test Methods 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 230000008133 cognitive development Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 210000005110 dorsal hippocampus Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 235000019680 high-energy food Nutrition 0.000 description 1
- 230000027984 hippocampus development Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000009021 linear effect Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- -1 maltodextrin Chemical class 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003923 mental ability Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 235000021457 non-caloric beverage Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000031836 visual learning Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to the field of infant nutrition and the effect of the maltodextrin of the early in life diet on the cognition and brain development later in life.
- Lactose is the primary carbohydrate in human breast milk and milk-based formulas for infants (Crisa, et al. 2013).
- lactose-free or reduced- lactose formulas have been increasingly used containing other carbohydrates than lactose (Green Corkins, et al. 2016), mainly driven by the increasing concern surrounding lactose intolerance in infants ⁇ Maldonado, et al. 1998 ⁇ .
- some authorized glycaemic carbohydrates like maltodextrin, are commonly used in infant and follow-on formulas as alternative sources of carbohydrates (European Union, 2015).
- maltodextrin as a source of digestible carbohydrates in infant formulas is suggested to help reducing osmotic load and related intestinal distress ⁇ Hofman, et al. 2016 ⁇ , while having no adverse effects on growth ⁇ Heubi, et al. 2000 ⁇ .
- Maltodextrin is generally considered safe for infant development but its use in infant formulas is often criticized with a lot of misconceptions. It can be suggested to avoid or limit the consumption of maltodextrin because it could be dangerous for infant health and cause malnutrition and health problems. It can be said that the baby will become trained to love super-sweet flavors because parents are often concerned about maltodextrin being added to formula as a sweetener. In addition, little is was known on the impact of a prolonged intake of a maltodextrin-based milk formula replacing lactose-based formula for health and biological functioning later in life, and more particularly on the cognition and brain development.
- Carbohydrates notably, are the primary source of energy for the development and growth of infants, and glucose, obtained from the digestion and absorption of complex carbohydrates, is the exclusive energy source for perinatal brain development under physiological conditions in humans and animals ⁇ Caravas, et al. 2014; Vannucci, et al. 2000 ⁇ .
- the patent EP 2 422 629 A 1 refers to a method for enhancing cognition and/or improving the memory of a subject that include administering a nutritional composition including maltodextrin as a carbohydrate source.
- the nutritional composition is administered such as a single dose of maltodextrin and effects are observed several hours after the intake of the nutritional composition.
- the patent FR 2 884 422 A1 refers to an intestinal anti-inflammatory composition enriched with fibers characterized in that it comprises branched maltodextrins having a total fiber content of greater than 50% on a dry matter basis.
- the inventors examine the effects of formulas containing maltodextrin or lactose as the main source of carbohydrates on later life cognitive performance of mammals. Growth and preferences of pigs for sweet caloric or non-caloric solutions have also been assessed to evaluate the potential impact of motivational factors on performance during the holeboard task.
- the pig an omnivorous species with high cognitive abilities ⁇ Dilger, et al. 2010 ; Gieling, et al. 201 1 ; Kornum, et al. 201 1 ⁇ , shares multiple similarities with humans in terms of nutritional needs, as well as brain development, physiology and function ⁇ Dobbing, et al. 1979; Lind, et al. 2007 ; Roura, et al. 2016 ⁇ , and it is thus an excellent animal model to study the impact of early nutrition on cognitive and behavioural development of human infants ⁇ Clouard, et al. 2012 ; Roura, et al. 2016 ⁇ .
- the inventors have demonstrated for the first time the beneficial effects of using maltodextrin as the main carbohydrate source in infant formulas compared to lactose on later life cognitive functions of mammals .
- This invention relates to the use of a digestible maltodextrin having a dextrose equivalent (DE) of between 15 to 19 or a composition comprising thereof in the early childhood of a mammal for enhancing or improving cognition and/or stimulating brain development at adult age of said mammal.
- DE dextrose equivalent
- the invention also concerns the use of a maltodextrin or a composition comprising thereof in an infant composition or formula-fed infants or growing up milk for enhancing cognition and/or stimulating brain development at the childhood or adult age of said infant.
- the present invention demonstrates that replacing lactose with maltodextrin in milk formulas for several weeks during early life induce beneficial effects on cognition by stimulating neurocognitive development compared to standard lactose-based milk formula.
- the results allow removing prejudices and bring arguments to counter the deleterious effects reported about the infant's consumption of maltodextrins by highlighting positive effects on cognition and brain development.
- maltodextrin used to replace lactose in milk formula are completely digestible without fiber content, contrary to branched maltodextrins cited in the patent FR 2 884 422 A1 which have a total fiber content of greater than 50% on a dry matter basis.
- the term "mammal” refers to all animals that belong to the class mammalia. Typically it includes for example, a mouse, rat, bat, dog, cat, rabbit, whale, horse, deer, sheep, goat, buffalo, elk, bear, coyote, mountain lion, raccoon, fox, monkey or human.
- the animal model chosen is a classically mammal model, the pig which is an omnivorous species with high cognitive abilities ⁇ Dilger, et al. 2010 #24;Gieling, et al. 2011 ;Kornum, et al. 2011 ⁇ , shares multiple similarities with humans in terms of nutritional needs, as well as brain development, physiology and function ⁇ Dobbing, et al. 1979; Lind, et al. 2007; Roura, et al. 2016 ⁇ , and it is thus an excellent animal model to study the impact of early nutrition on cognitive and behavioural development of human infants ⁇ Clouard, et al. 2012; Roura, et al. 2016 ⁇ .
- The“early childhood” for a mammal refers to the early period of life after birth. In particular for human, it is between 0 to 36 months.
- infant as used in the present invention are mammals in the early childhood period, for example for human the infant is aged from after birth to 3 years.
- the terms“childhood” refers to a period after the early childhood to the period before the sexual maturity. In particular for human, it is the period between 3 years to 13 years (before beginning of teenage period).
- the terms“adult age” or“adult mammal” refers to a mammal which has reached sexual maturity.
- the terms“improve,”“improving” or“improvement” or grammatical variations thereof used in relation to cognitive functions refer to the ability to achieve a measurable increase in performance in relation to tasks used to test these cognitive functions in mammals.
- the terms“improving or enhancing cognition at childhood or adult age” and/or“improving memory at childhood or adult age” refers to the measurement of an improvement or an enhancement of cognition or memory at childhood or adult age between two childhood or adult mammals one which has received the nutrition enriched in maltodextrins during early childhood age and the other who has not.
- maltodextrins are administrated at an early childhood age and notably chronically administrated for example daily or weekly during at least one week to 36 months, preferably 2 weeks to 20 months, typically, 5 weeks to 15 months of the early childhood period.
- the improvement or enhancement of cognition or memory is observed at the childhood or the adult age, meaning a long time after the end of administration of the maltodextrins.
- the term “cognition” should be understood as meaning the short-term and / or long-term memory as well as the cognitive flexibility ⁇ Gieling, et al. 2012 ⁇ van der Staay, et al. 2012 ⁇
- Cognitive flexibility refers to the ability to execute multiple mental tasks simultaneously, to switch from one task to the next easily, and restructure knowledge and strategy to tackle changing tasks. It has been described as the mental ability to control what one is thinking about, how one is thinking about it, and to change one's mind about it. Normal or physiological cognitive flexibility is demonstrated by an animal when it is required to change its thinking about a subject in response to a new set of rules, requiring the animal to perform a previously learned task under a new set of rules sometimes in a new environment.
- memory is defined as the biological processes of the brain that enable storage and recall of information.
- memory refers to the short-term memory and the long-term memory.
- the “holeboard” test provides several scores used to evaluate cognition the working memory scores and the reference memory scores.
- the Holeboard task consists of finding 4 rewards placed in 4 buckets among 16 proposed buckets with a defined configuration. The trial ended when the individual found all 4 rewards or after 180 sec (maximal timing defined to perform the task).
- the working memory (WM) score corresponds to the short-term memory and is calculated as the ratio between the number of rewarded visits and the number of visits and revisits to the baited set of buckets.
- the reference memory (RM) score corresponds to the long term memory and is calculated as the ratio between the number of visits and revisits to the set of baited buckets and the number of visits and revisits to all buckets.
- the improvement or an enhancement of memory refers more particularly to the improvement of the long-term memory.
- the long term memory reflects notably the capacity of memorization from one session to another.
- the improvement or an enhancement of the cognition is the omprovement of enhancement of cognitive flexibility
- cognitive flexibility reflects the improvement of the adaptation to a new spatial configuration
- the expression“stimulating brain development” refers to the stimulation of development of the area responsible of spatial cognition and more particularly the hippocampus.
- the inventors have demonstrated an improvement of RM but not WM due to absorption of maltodextrins in early stage and these parameters reflecting a better spatial long-term memory have been demonstrated to be linked to hippocampus area ( ⁇ Yoon, et al. 2008 ⁇ . ⁇ Pothuizen, et al. 2004 ⁇ Sloan, et al. 2006 ⁇ )
- effective amount refers to that amount of maltodextrins that will, when administered to the mammal, enhances cognition and/or improves memory of said mammal at a childhood or an adult age and/or stimulates the brain development of said mammal, without any significant adverse side effect, as compared to untreated mammals.
- effective amounts of maltodextrins for use in the present invention will vary somewhat depending upon the particular species of animal or growth conditions such as temperature and type of feed, and the like. For any particular case, the exact or optimal effective amount to be administered can be determined by conventional dose titration techniques.
- maltodextrin refers to partially hydrolyzated starch and is digestible. Maltodextrins are defined by the European and US regulation as products having a dextrose equivalent (DE) less than 20. Starch hydrolysates are generally produced by heat, acid, or enzymes. This process breaks down the starch and converts some of the starch to dextrose. With adjustments, this process yields more or less dextrose. Typically the maltodextrins of the invention are digestible maltodextrins. Maltodextrins are therefore classified by dextrose equivalence.
- Dextrose equivalents are a measure of the reducing sugars present calculated as dextrose and expressed as a percentage of the total dry substance.
- Maltodextrins can have a dextrose equivalent of up to 20. At above 20 DE, the product is then generally classified as corn syrup solids, which are completely soluble and impart significant sweetness.
- the maltodextrin of the invention has a DE of between 5 to 20, typically between 10 to 19, more preferably, 15 to 19.
- Digestible maltodextrin is a low-sweet saccharide polymer consisting of D- glucose units primarily linked linearly with a-1 ,4 bonds; it also has a branched structure through a-1 ,6 bonds. Maltodextrin has an approximate energy value of 4 kcal/g, and is the main carbohydrate source in non-allergenic infant formulas containing non-dairy ingredients ⁇ Hofman, et al., 2016 ⁇
- the maltodextrins are administrated in the form of nutritional composition or is comprised in a dietary supplement.
- the invention also concerns the use of a maltodextrin composition which may be a nutritional composition for an early childhood mammals including, but not limited to, a formula-fed infant or a growing up milk but also, dairy product, biscuit, bakery, pastry and bread, sauce, soup, prepared food, frozen food, confectionary, instant product, drinks and shake and chocolate product.
- a maltodextrin composition which may be a nutritional composition for an early childhood mammals including, but not limited to, a formula-fed infant or a growing up milk but also, dairy product, biscuit, bakery, pastry and bread, sauce, soup, prepared food, frozen food, confectionary, instant product, drinks and shake and chocolate product.
- said nutritional composition may be comprising:
- proteins preferably vegetable proteins (i.e. , wheat protein, soy protein, rice protein, potato protein, pea protein, canola protein and mixtures thereof) or animal proteins (i.e., whey protein) and mixtures thereof;
- fat preferably selected among vegetal oil, animal lipids (i.e. tallow, milk lipids, lard... ) and mix thereof.
- the protein source may be provided in concentrate form, hydrolysate form, or isolate form, however the hydrolyzed form is particularly preferred.
- Said animal protein may be selected among milk protein, whey protein, casein protein, and mixtures thereof.
- Figure 1 The four configurations of baited buckets in the holeboard arena. Piglets were assigned to a fixed configuration during the acquisition phase, and to another configuration during the reversal phase (A to C, B to D, C to A, and D to B).
- Figure 2. Performance during the acquisition and reversals phases of the spatial holeboard task in piglets fed a lactose-based formula or a maltodextrin-based formula from 1 to 9 weeks of age.
- Figure 3 Changes of performance between the last block of acquisition trials and the first block of reversal trials in a spatial holeboard task of piglets fed a lactose-based formula or a maltodextrin-based formula from 1 to 9 weeks of age. During the reversal phase, the configuration of rewarded buckets was changed to address cognitive flexibility of the piglets.
- Figure 4 Intake (kg/kg of BW) of sucralose or sucrose solutions offered during 30- min single-solution tests to piglets fed a lactose-based formula or a maltodextrin- based formula from 1 to 9 weeks of age, and intake (kg/kg of BW) of feed during the 4 hours following the distribution of the solution.
- Sows and their litter were kept together continuously in the farrowing unit until 2 weeks after the expected farrowing date (15 ⁇ 0.5 days after birth). From 2 to 5 weeks of age, the piglets were subjected to an intermittent suckling (IS) regimen, during which sows were separated from their litter for 8h/day (7:30 to 15:30). During separation, sows were housed individually in a separated room (IS unit) to prevent visual and auditory contact. This procedure allowed to start the dietary intervention at a very young age and stimulate the intake of the formulas, while avoiding stress-related developmental issues that can be caused by a total and early separation from the sow. During lactation, sows were fed twice a day (1 meal in the morning in the IS unit and 1 meal in the afternoon after return to the farrowing unit) a standard commercial diet according to the normal net energy recommendations for lactating sows.
- IS intermittent suckling
- piglets were separated from the sows.
- 8 healthy piglets (4 females and 4 males) with birth weights closest to the average birth weight of the litter were selected from each of the 8 litters and were transported to the experimental farm of Carus (Wageningen University & Research, The Netherlands). Exclusion criteria for selection were very small, sick, lame or weak piglets.
- the 64 selected piglets were housed in groups of 4 littermates (no mixing), with 2 females and 2 males per pen (280 cm c 180 cm) in 2 identical and adjacent rooms. Pens were equipped with a chain with screws attached to it as enrichment material. Fresh wood shavings were added daily to the pens as bedding.
- piglets had access to the sow milk only.
- the lactose-based formula was a commercial formula containing lactose as the main carbohydrate (28% of nutrient composition).
- the maltodextrin formula consisted in the same formula in which lactose was replaced with maltodextrin (28% of nutrient composition, DE 19).
- the formulas were obtained by mixing milk powder in lukewarm water, with a milk powder to water ratio of 1 :4. Ingredient and nutrient compositions of the milk powders are indicated in Table 1.
- Piglets received the formulas from 1 to 9 weeks of age (i.e. 8 to 67 days after birth). Piglets were fed the formulas via milk dispensers, equipped with 1 rescue cup before separation from the sows (1 to 5 weeks of age), and 4 rescue cups mounted in series after separation from the sows (5 to 9 weeks of age). Throughout the entire dietary intervention, formulas were distributed in two meals, at approximately 08:30 and 16:30. Milk dispensers were cleaned daily with hot water, weekly with a basic solution, and monthly with an acidic solution. Allocation of the litters to the formulas were balanced for sow parity, average litter size, and weight at birth. Treatments were distributed in a randomized design within rooms before separation from the sows, and within and between rooms after separation from the sows.
- piglets From 5 weeks of age onwards (i.e. at separation from the sow), piglets also had restricted access to a commercial creep feed (250 g/pen/day) for 2 h/day to habituate them to solid feed. At 67 days of age, piglets were weaned from milk to a commercial starter diet, over a 3-day transition phase. The starter diet was then offered to the piglets ad libitum until the end of the experiment. Piglets had ad libitum access to water throughout the whole experiment.
- piglets were weighed individually at birth, at the start of the dietary intervention, at separation from the sows, and at the start and end of holeboard testing, i.e. at 1 , 5, 12 and 17 weeks of age, respectively.
- piglets were gradually habituated to the experimenters, the buckets and rewards, the corridor leading to the test room, the testing room and the task in sessions of 10-15 min per day for 13 work days.
- piglets were allowed to explore the holeboard arena, in which the 16 buckets were baited, with their pen mates for 4 days, and individually for 3 days. Piglets were then subjected to individual habituation trials in which only 8 buckets were baited, with at least 2 trials of maximum 3 min per day for 4 days.
- 2 piglets (1 male and 1 female) were selected per pen based on the responses during the trials. Selection criteria were liking/eating chocolate raisins, showing no extreme stress responses (high-pitch vocalizations, standing alert, escape attempts) when alone in the holeboard arena, and performing the task (i.e. looking in the buckets).
- piglets were individually subjected to 2 massed trials per day on 14 consecutive work days, i.e. 28 acquisition trials. While a piglet was tested, its pen mates were kept in the waiting area. The trial started when the piglet had its 4 legs in the testing arena and ended when the piglet found all 4 rewards or after 180 sec. Every time the piglet visited a baited bucket for the first time, a clicker sound was produced to facilitate learning. If the piglet completed the task (i.e. found the 4 rewards in less than 180 sec), a bike bell was rang, the exit guillotine door was opened, and the piglet was congratulated (“good job!”,“well done!”), and received a piece of apple.
- Each piglet was tested on a fixed configuration of baited buckets throughout the acquisition phase, with the configuration of baited buckets differing between the 2 piglets within each pen, and being balanced between formulas and rooms. Testing order within and between pens was alternated within and between days to balance for formulas. Two different entrances were used per day of test (i.e. 1 entrance per trial).
- the following parameters were scored live using The Observer XT (Noldus Information Technology, Wageningen, The Netherlands): all visits and revisits to all buckets, latencies to all bucket visits, trial duration, total number of defecations, urinations and escape attempts during the trial. From the parameters recorded during the test, the following variables were calculated a posteriori according to ⁇ van der Staay, et al.
- working memory (WM) score i.e., short-term memory
- RM reference memory
- WM working memory
- RM long-term memory
- WM errors the number of revisits to baited buckets
- RM errors the number of visits and revisits to unbaited buckets
- trial duration is the time needed to complete the task, i.e.
- piglets were subjected to 2 consecutive single solution consumption tests to assess whether the main source of carbohydrates in early life affects attractiveness for caloric and non-caloric sweet solutions later in life.
- piglets of half of the pens were given access to a 10% (w/w) sucrose solution, and piglets of the other half of the pens to a 0.125% (w/w) sucralose solution for 30 min/day (10:00-10:30).
- piglets were offered access to the other solution for another 2-day test; the 2-day tests were separated by the week-end. Order of solution distribution was balanced for treatment and room. On each day of testing, the piglets were deprived from feed for 2.5 hours before starting the test.
- Performance in the acquisition phase was significantly affected by trial blocks ( Figure 2).
- WM and RM scores increased linearly, while WM and RM errors, trial duration and total number of visits decreased linearly over trial blocks ( P ⁇ 0.0001 for all).
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Pediatric Medicine (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Abstract
The invention concerns the use of a maltodextrin or a composition comprising thereof as the main source of carbohydrates in infant nutrition during the early childhood of a mammal for improving or enhancing cognitive performance and/or stimulating brain development.
Description
Use of Maltodextrin for enhancing or improving cognition and/or stimulating brain development
Field of the invention
The present invention relates to the field of infant nutrition and the effect of the maltodextrin of the early in life diet on the cognition and brain development later in life.
Background of the invention
Lactose is the primary carbohydrate in human breast milk and milk-based formulas for infants (Crisa, et al. 2013). In recent years, lactose-free or reduced- lactose formulas have been increasingly used containing other carbohydrates than lactose (Green Corkins, et al. 2016), mainly driven by the increasing concern surrounding lactose intolerance in infants {Maldonado, et al. 1998}. In the European Union, some authorized glycaemic carbohydrates, like maltodextrin, are commonly used in infant and follow-on formulas as alternative sources of carbohydrates (European Union, 2015). The use of maltodextrin as a source of digestible carbohydrates in infant formulas is suggested to help reducing osmotic load and related intestinal distress {Hofman, et al. 2016 }, while having no adverse effects on growth {Heubi, et al. 2000 }.
Maltodextrin is generally considered safe for infant development but its use in infant formulas is often criticized with a lot of misconceptions. It can be suggested to avoid or limit the consumption of maltodextrin because it could be dangerous for infant health and cause malnutrition and health problems. It can be said that the baby will become trained to love super-sweet flavors because parents are often concerned about maltodextrin being added to formula as a sweetener. In addition, little is was known on the impact of a prolonged intake of a maltodextrin-based milk formula replacing lactose-based formula for health and biological functioning later in life, and more particularly on the cognition and brain development. Early nutrition can influence development and may result in long-lasting adaptations of metabolic, immune, behavioural and brain functions in later life, a phenomenon known as nutritional programming {Benton, et al. 2008; Bolton, et al. 2014 ; Langley-Evans, et al. 2009; Moody, et al. 2017; Patel, et al. 2009 }.
Carbohydrates, notably, are the primary source of energy for the development and growth of infants, and glucose, obtained from the digestion and absorption of complex carbohydrates, is the exclusive energy source for perinatal brain development under physiological conditions in humans and animals {Caravas, et al. 2014; Vannucci, et al. 2000}. The quality and quantity of carbohydrates consumed in early life have been found to shape offspring’ metabolic profile {Tzanetakou, et al. 201 1 } and food preferences {Stephen, et al. 2012 }. Surprisingly, however, little is known on the relation between early carbohydrate intake and neuro-cognitive development {Stephen, et al. 2012 }. Yet, increased carbohydrate intake in the immediate postnatal life results in behavioural, metabolic, and physical alterations in rats (e.g. hyperphagia, hyperinsulinemia and weight gain){Patel, et al. 2009 }, while intake of carbohydrates with low glycaemic index, measuring the rate at which carbohydrates raise blood glucose levels after ingestion, during pregnancy improves maternal glycaemic control, but also insulin and glucose regulation in the offspring {Tzanetakou, et al. 2011 }. Furthermore, infants fed glucose syrup-containing formulas show different postprandial metabolic responses than infants fed lactose- containing formulas, with, notably, alterations of blood glucose levels {Slupsky, et al. 2017 }. If the source of carbohydrates ingested during a sensitive period of (brain) development can influence (long-term) metabolic functioning of the infant, it is safe to assume that it may also have long-lasting consequences on brain development and cognitive function. No studies have yet investigated the impact of replacing lactose with another source of carbohydrates on later life cognitive functions in formula-fed infants.
The patent EP 2 422 629 A 1 refers to a method for enhancing cognition and/or improving the memory of a subject that include administering a nutritional composition including maltodextrin as a carbohydrate source. The nutritional composition is administered such as a single dose of maltodextrin and effects are observed several hours after the intake of the nutritional composition.
The patent FR 2 884 422 A1 refers to an intestinal anti-inflammatory composition enriched with fibers characterized in that it comprises branched maltodextrins having a total fiber content of greater than 50% on a dry matter basis.
The inventors examine the effects of formulas containing maltodextrin or lactose as the main source of carbohydrates on later life cognitive performance of mammals. Growth and preferences of pigs for sweet caloric or non-caloric solutions
have also been assessed to evaluate the potential impact of motivational factors on performance during the holeboard task. The pig, an omnivorous species with high cognitive abilities {Dilger, et al. 2010 ; Gieling, et al. 201 1 ; Kornum, et al. 201 1 }, shares multiple similarities with humans in terms of nutritional needs, as well as brain development, physiology and function {Dobbing, et al. 1979; Lind, et al. 2007 ; Roura, et al. 2016 }, and it is thus an excellent animal model to study the impact of early nutrition on cognitive and behavioural development of human infants {Clouard, et al. 2012 ; Roura, et al. 2016}.
The inventors have demonstrated for the first time the beneficial effects of using maltodextrin as the main carbohydrate source in infant formulas compared to lactose on later life cognitive functions of mammals .
Summary of the invention
This invention relates to the use of a digestible maltodextrin having a dextrose equivalent (DE) of between 15 to 19 or a composition comprising thereof in the early childhood of a mammal for enhancing or improving cognition and/or stimulating brain development at adult age of said mammal. Preferably by administrating to said mammal an effective amount of maltodextrins during the early childhood.
The invention also concerns the use of a maltodextrin or a composition comprising thereof in an infant composition or formula-fed infants or growing up milk for enhancing cognition and/or stimulating brain development at the childhood or adult age of said infant.
The present invention demonstrates that replacing lactose with maltodextrin in milk formulas for several weeks during early life induce beneficial effects on cognition by stimulating neurocognitive development compared to standard lactose-based milk formula. The results allow removing prejudices and bring arguments to counter the deleterious effects reported about the infant's consumption of maltodextrins by highlighting positive effects on cognition and brain development.
In the present invention, maltodextrin used to replace lactose in milk formula are completely digestible without fiber content, contrary to branched maltodextrins cited in the patent FR 2 884 422 A1 which have a total fiber content of greater than 50% on a dry matter basis.
As used herein, the term "mammal" refers to all animals that belong to the class mammalia. Typically it includes for example, a mouse, rat, bat, dog, cat, rabbit, whale, horse, deer, sheep, goat, buffalo, elk, bear, coyote, mountain lion, raccoon, fox, monkey or human.
In the study hereunder, the animal model chosen is a classically mammal model, the pig which is an omnivorous species with high cognitive abilities {Dilger, et al. 2010 #24;Gieling, et al. 2011 ;Kornum, et al. 2011}, shares multiple similarities with humans in terms of nutritional needs, as well as brain development, physiology and function {Dobbing, et al. 1979; Lind, et al. 2007; Roura, et al. 2016}, and it is thus an excellent animal model to study the impact of early nutrition on cognitive and behavioural development of human infants {Clouard, et al. 2012; Roura, et al. 2016 }.
The“early childhood” for a mammal refers to the early period of life after birth. In particular for human, it is between 0 to 36 months.
According to the invention, “infant” as used in the present invention are mammals in the early childhood period, for example for human the infant is aged from after birth to 3 years.
According to the invention, the terms“childhood” refers to a period after the early childhood to the period before the sexual maturity. In particular for human, it is the period between 3 years to 13 years (before beginning of teenage period).
According to the invention, the terms“adult age” or“adult mammal” refers to a mammal which has reached sexual maturity.
The terms“improve,”“improving” or“improvement” or grammatical variations thereof used in relation to cognitive functions refer to the ability to achieve a measurable increase in performance in relation to tasks used to test these cognitive functions in mammals.
The terms“improving or enhancing cognition at childhood or adult age” and/or“improving memory at childhood or adult age” refers to the measurement of an improvement or an enhancement of cognition or memory at childhood or adult age between two childhood or adult mammals one which has received the nutrition enriched in maltodextrins during early childhood age and the other who has not. Indeed, according to the invention, although maltodextrins are administrated at an early childhood age and notably chronically administrated for example daily or weekly during at least one week to 36 months, preferably 2 weeks to 20 months, typically, 5 weeks to 15 months of the early childhood period. The improvement or enhancement
of cognition or memory is observed at the childhood or the adult age, meaning a long time after the end of administration of the maltodextrins. In the case of pig, the improvement or an enhancement of cognition or memory has been evaluated between 12 and 17 weeks. Consequently, the period between the end of the treatment and the observation of an improvement of improvement or an enhancement of cognition or memory is between 3 and 8 weeks meaning a period which is of about a third or a fourth of the pig lifespan. This effect is called“nutritional programming”. It was very surprising that such nutritional programming effect can be induced by the absorption and notably chronical absorption of maltodextrins.
The improvement or an enhancement of cognition have been evaluated using the“holeboard” test which is well known to assess learning, working and reference memory, as well as cognitive flexibility (i.e. ability to respond to a new spatial configuration, also called‘reversal’) {van der Staay, 2012 }.
According to the invention the term “cognition” should be understood as meaning the short-term and / or long-term memory as well as the cognitive flexibility {Gieling, et al. 2012 }{van der Staay, et al. 2012 }
The terms“Cognitive flexibility” refers to the ability to execute multiple mental tasks simultaneously, to switch from one task to the next easily, and restructure knowledge and strategy to tackle changing tasks. It has been described as the mental ability to control what one is thinking about, how one is thinking about it, and to change one's mind about it. Normal or physiological cognitive flexibility is demonstrated by an animal when it is required to change its thinking about a subject in response to a new set of rules, requiring the animal to perform a previously learned task under a new set of rules sometimes in a new environment.
The term“memory” is defined as the biological processes of the brain that enable storage and recall of information. The term“memory” refers to the short-term memory and the long-term memory.
The “holeboard” test (or Holeboard task) provides several scores used to evaluate cognition the working memory scores and the reference memory scores. The Holeboard task consists of finding 4 rewards placed in 4 buckets among 16 proposed buckets with a defined configuration. The trial ended when the individual found all 4 rewards or after 180 sec (maximal timing defined to perform the task). The working memory (WM) score corresponds to the short-term memory and is calculated as the ratio between the number of rewarded visits and the number of visits and revisits to
the baited set of buckets. The reference memory (RM) score corresponds to the long term memory and is calculated as the ratio between the number of visits and revisits to the set of baited buckets and the number of visits and revisits to all buckets.
Typically, the improvement or an enhancement of memory refers more particularly to the improvement of the long-term memory. The long term memory reflects notably the capacity of memorization from one session to another.
Typically, the improvement or an enhancement of the cognition is the omprovement of enhancement of cognitive flexibility cognitive flexibility reflects the improvement of the adaptation to a new spatial configuration.
The expression“stimulating brain development” refers to the stimulation of development of the area responsible of spatial cognition and more particularly the hippocampus. The inventors have demonstrated an improvement of RM but not WM due to absorption of maltodextrins in early stage and these parameters reflecting a better spatial long-term memory have been demonstrated to be linked to hippocampus area ({Yoon, et al. 2008 }. {Pothuizen, et al. 2004 }{Sloan, et al. 2006 })
The term "effective amount" refers to that amount of maltodextrins that will, when administered to the mammal, enhances cognition and/or improves memory of said mammal at a childhood or an adult age and/or stimulates the brain development of said mammal, without any significant adverse side effect, as compared to untreated mammals. As appreciated in the art, effective amounts of maltodextrins for use in the present invention will vary somewhat depending upon the particular species of animal or growth conditions such as temperature and type of feed, and the like. For any particular case, the exact or optimal effective amount to be administered can be determined by conventional dose titration techniques.
As used herein, the term "maltodextrin" refers to partially hydrolyzated starch and is digestible. Maltodextrins are defined by the European and US regulation as products having a dextrose equivalent (DE) less than 20. Starch hydrolysates are generally produced by heat, acid, or enzymes. This process breaks down the starch and converts some of the starch to dextrose. With adjustments, this process yields more or less dextrose. Typically the maltodextrins of the invention are digestible maltodextrins. Maltodextrins are therefore classified by dextrose equivalence. Dextrose equivalents are a measure of the reducing sugars present calculated as dextrose and expressed as a percentage of the total dry substance. Maltodextrins can have a dextrose equivalent of up to 20. At above 20 DE, the product is then generally
classified as corn syrup solids, which are completely soluble and impart significant sweetness. Typically the maltodextrin of the invention has a DE of between 5 to 20, typically between 10 to 19, more preferably, 15 to 19.
Digestible maltodextrin is a low-sweet saccharide polymer consisting of D- glucose units primarily linked linearly with a-1 ,4 bonds; it also has a branched structure through a-1 ,6 bonds. Maltodextrin has an approximate energy value of 4 kcal/g, and is the main carbohydrate source in non-allergenic infant formulas containing non-dairy ingredients {Hofman, et al., 2016 }
Preferably, the maltodextrins are administrated in the form of nutritional composition or is comprised in a dietary supplement.
The invention also concerns the use of a maltodextrin composition which may be a nutritional composition for an early childhood mammals including, but not limited to, a formula-fed infant or a growing up milk but also, dairy product, biscuit, bakery, pastry and bread, sauce, soup, prepared food, frozen food, confectionary, instant product, drinks and shake and chocolate product.
Typically said nutritional composition may be comprising:
20 to 30%, preferably 22 to 28 % of proteins preferably vegetable proteins (i.e. , wheat protein, soy protein, rice protein, potato protein, pea protein, canola protein and mixtures thereof) or animal proteins (i.e., whey protein) and mixtures thereof;
20 to 40%, preferably, 25% to 35% of maltodextrin
20 to 40%, preferably 25 to 35% of fat, preferably selected among vegetal oil, animal lipids (i.e. tallow, milk lipids, lard... ) and mix thereof.
The protein source may be provided in concentrate form, hydrolysate form, or isolate form, however the hydrolyzed form is particularly preferred.
Said animal protein may be selected among milk protein, whey protein, casein protein, and mixtures thereof.
The present invention will be further illustrated by the additional description and drawings which follow, which refer to examples illustrating
It should be understood however that these examples are given only by way of illustration of the invention and do not constitute in anyway a limitation thereof.
BRIEF DESCRIPTION OF THE FIGURES
Figure 1. The four configurations of baited buckets in the holeboard arena. Piglets were assigned to a fixed configuration during the acquisition phase, and to another configuration during the reversal phase (A to C, B to D, C to A, and D to B). Figure 2. Performance during the acquisition and reversals phases of the spatial holeboard task in piglets fed a lactose-based formula or a maltodextrin-based formula from 1 to 9 weeks of age.
Figure 3. Changes of performance between the last block of acquisition trials and the first block of reversal trials in a spatial holeboard task of piglets fed a lactose-based formula or a maltodextrin-based formula from 1 to 9 weeks of age. During the reversal phase, the configuration of rewarded buckets was changed to address cognitive flexibility of the piglets.
Figure 4. Intake (kg/kg of BW) of sucralose or sucrose solutions offered during 30- min single-solution tests to piglets fed a lactose-based formula or a maltodextrin- based formula from 1 to 9 weeks of age, and intake (kg/kg of BW) of feed during the 4 hours following the distribution of the solution.
Detailed description of the invention EXAMPLE
METHODS
The Animal Welfare Body of Wageningen University & Research has approved this experiment.
Animals and housing A total of 8 multiparous sows (Topigs 20) and their litters (Tempo c Topigs 20) from the Swine Innovation Centre of Wageningen University & Research (VIC, Sterksel, The Netherlands) were used. Lactating sows and their litters were housed in individual farrowing pens (240 cm c 180 cm) equipped with a farrowing crate. A jute bag was provided around parturition to be used as nesting material. Rooms had a natural light-
dark cycle. Ambient temperature at arrival of the sows to the farrowing unit, one week before the expected farrowing date, was 25°C and was decreased over lactation via a floor cooling system. From birth onwards, piglets had access to a heated area. Within 24 to 48 hours after birth, if needed, piglets were cross-fostered between sows to balance litter sizes based on the number of functional teats.
Sows and their litter were kept together continuously in the farrowing unit until 2 weeks after the expected farrowing date (15 ± 0.5 days after birth). From 2 to 5 weeks of age, the piglets were subjected to an intermittent suckling (IS) regimen, during which sows were separated from their litter for 8h/day (7:30 to 15:30). During separation, sows were housed individually in a separated room (IS unit) to prevent visual and auditory contact. This procedure allowed to start the dietary intervention at a very young age and stimulate the intake of the formulas, while avoiding stress-related developmental issues that can be caused by a total and early separation from the sow. During lactation, sows were fed twice a day (1 meal in the morning in the IS unit and 1 meal in the afternoon after return to the farrowing unit) a standard commercial diet according to the normal net energy recommendations for lactating sows.
At about 5 weeks of age (36 ± 0.5 days after birth), piglets were separated from the sows. At separation from the sows, 8 healthy piglets (4 females and 4 males) with birth weights closest to the average birth weight of the litter were selected from each of the 8 litters and were transported to the experimental farm of Carus (Wageningen University & Research, The Netherlands). Exclusion criteria for selection were very small, sick, lame or weak piglets. The 64 selected piglets were housed in groups of 4 littermates (no mixing), with 2 females and 2 males per pen (280 cm c 180 cm) in 2 identical and adjacent rooms. Pens were equipped with a chain with screws attached to it as enrichment material. Fresh wood shavings were added daily to the pens as bedding. Fresh straw was added daily to the pens from the end of the dietary intervention onwards, at about 9-10 weeks of age (67 ± 0.5 days after birth). Room temperature at arrival of the piglets was 25°C and was then gradually decreased and kept at 21 °C until the end of the experiment. Lights were on and a radio was playing in the background from 7:00 to 19:00 daily.
Formulas and diets
For the first week of life, piglets had access to the sow milk only. At 1 week of age, litters of piglets (n = 4 litters/treatment) were allocated to 1 of 2 formulas differing in their main carbohydrate source. The lactose-based formula was a commercial formula containing lactose as the main carbohydrate (28% of nutrient composition). The maltodextrin formula consisted in the same formula in which lactose was replaced with maltodextrin (28% of nutrient composition, DE 19). The formulas were obtained by mixing milk powder in lukewarm water, with a milk powder to water ratio of 1 :4. Ingredient and nutrient compositions of the milk powders are indicated in Table 1.
Table 1. Ingredient and nutrient compositions of the experimental milk powders
Piglets received the formulas from 1 to 9 weeks of age (i.e. 8 to 67 days after birth). Piglets were fed the formulas via milk dispensers, equipped with 1 rescue cup before separation from the sows (1 to 5 weeks of age), and 4 rescue cups mounted in series after separation from the sows (5 to 9 weeks of age). Throughout the entire dietary intervention, formulas were distributed in two meals, at approximately 08:30 and 16:30. Milk dispensers were cleaned daily with hot water, weekly with a basic solution, and monthly with an acidic solution. Allocation of the litters to the formulas were balanced for sow parity, average litter size, and weight at birth. Treatments were distributed in a randomized design within rooms before separation from the sows, and within and between rooms after separation from the sows.
From 5 weeks of age onwards (i.e. at separation from the sow), piglets also had restricted access to a commercial creep feed (250 g/pen/day) for 2 h/day to habituate them to solid feed. At 67 days of age, piglets were weaned from milk to a commercial starter diet, over a 3-day transition phase. The starter diet was then offered to the piglets ad libitum until the end of the experiment. Piglets had ad libitum access to water throughout the whole experiment.
Measurements
To assess the effect of formulas on piglet growth, piglets were weighed individually at birth, at the start of the dietary intervention, at separation from the sows, and at the start and end of holeboard testing, i.e. at 1 , 5, 12 and 17 weeks of age, respectively.
Spatial cognitive holeboard task
From 12 to 17 weeks of age (i.e. 3 to 8 weeks after the end of the dietary intervention), 2 piglets (1 male and 1 female) per pen (n = 8 pens/treatment) were individually tested in a spatial holeboard task to assess learning, working and reference memory, as well as cognitive flexibility (i.e. ability to respond to a new spatial configuration, also called ‘reversal’) {van der Staay, et al. 2012 }. The test arena (5.3 m c 5.3 m) had black, wooden, 80-cm high walls and 4 entrances with guillotine doors. The arena was surrounded by a corridor, and a waiting area containing a jute bag and some toys that were changed daily. In the arena, 16 grey metallic buckets (diameter: 19 cm) were screwed to the floor in a 4 c 4 matrix (Figure 1). During the test, 4 of the buckets were
baited with a chocolate raisin. To prevent the use of visual cues to find the rewards, the chocolate raisins were hidden under a thin layer of grinded straw. All buckets also had a perforated false bottom under which fresh chocolate raisins were placed at the start of the day to prevent the use of odor cues to locate the baited buckets. Piglets were deprived from feed overnight during the 3 phases of holeboard testing (habituation, acquisition and reversal).
Before the start of the test, piglets were gradually habituated to the experimenters, the buckets and rewards, the corridor leading to the test room, the testing room and the task in sessions of 10-15 min per day for 13 work days. After 2 days of habituation to the experimenters, buckets and food rewards in the home pens, piglets were allowed to explore the holeboard arena, in which the 16 buckets were baited, with their pen mates for 4 days, and individually for 3 days. Piglets were then subjected to individual habituation trials in which only 8 buckets were baited, with at least 2 trials of maximum 3 min per day for 4 days. At the end of the 13-day habituation phase, 2 piglets (1 male and 1 female) were selected per pen based on the responses during the trials. Selection criteria were liking/eating chocolate raisins, showing no extreme stress responses (high-pitch vocalizations, standing alert, escape attempts) when alone in the holeboard arena, and performing the task (i.e. looking in the buckets).
After the habituation phase, piglets were individually subjected to 2 massed trials per day on 14 consecutive work days, i.e. 28 acquisition trials. While a piglet was tested, its pen mates were kept in the waiting area. The trial started when the piglet had its 4 legs in the testing arena and ended when the piglet found all 4 rewards or after 180 sec. Every time the piglet visited a baited bucket for the first time, a clicker sound was produced to facilitate learning. If the piglet completed the task (i.e. found the 4 rewards in less than 180 sec), a bike bell was rang, the exit guillotine door was opened, and the piglet was congratulated (“good job!”,“well done!”), and received a piece of apple. If the piglet did not complete the task within the 180 sec, a police siren sound was produced (distinctively different from the bike bell sound); the piglet was not congratulated and did not receive a piece of apple. After each trial, the piglet was led back into the waiting area with its pen mates. After 2 piglets per pen have been tested twice, all the pen mates were led back into their home pen and their feeder was opened. After each trial, feces were removed and urine was wiped from the testing
arena. In total 4 different configurations of baited buckets were used (Figure 1). Each piglet was tested on a fixed configuration of baited buckets throughout the acquisition phase, with the configuration of baited buckets differing between the 2 piglets within each pen, and being balanced between formulas and rooms. Testing order within and between pens was alternated within and between days to balance for formulas. Two different entrances were used per day of test (i.e. 1 entrance per trial).
After the acquisition phase was completed, piglets were tested in a reversal phase, with 16 reversal trials in 8 working days. The procedure was the same procedure as that of the acquisition phase, but piglets were assigned to a different configuration of baited buckets (Figure 1).
The following parameters were scored live using The Observer XT (Noldus Information Technology, Wageningen, The Netherlands): all visits and revisits to all buckets, latencies to all bucket visits, trial duration, total number of defecations, urinations and escape attempts during the trial. From the parameters recorded during the test, the following variables were calculated a posteriori according to {van der Staay, et al. 2012 }: working memory (WM) score (i.e., short-term memory) is the ratio between the number of rewarded visits and the number of visits and revisits to the baited set of buckets; reference memory (RM) score (i.e., long-term memory) is the ratio between the number of visits and revisits to the set of baited buckets and the number of visits and revisits to all buckets; WM errors is the number of revisits to baited buckets; RM errors is the number of visits and revisits to unbaited buckets; trial duration is the time needed to complete the task, i.e. latency to fourth baited bucket or 180 sec; inter-visit interval (I VI) is calculated as (time to last bucket visit - latency to first bucket visit) / (number of bucket visits - 1); total number of visits and revisits. Furthermore, difference in performance between the last block of the acquisition phase (block 7) and the first block of the reversal phase (block 8), i.e. transition phase, was assessed and represents a measure of cognitive flexibility after the switch of configuration {Antonides, et al. 2015; Antonides, et al. 2015 }.
Single-solution consumption test
Between 17 and 18 week of age, piglets were subjected to 2 consecutive single solution consumption tests to assess whether the main source of carbohydrates in
early life affects attractiveness for caloric and non-caloric sweet solutions later in life. On 2 consecutive days, piglets of half of the pens were given access to a 10% (w/w) sucrose solution, and piglets of the other half of the pens to a 0.125% (w/w) sucralose solution for 30 min/day (10:00-10:30). After the first 2-day test, piglets were offered access to the other solution for another 2-day test; the 2-day tests were separated by the week-end. Order of solution distribution was balanced for treatment and room. On each day of testing, the piglets were deprived from feed for 2.5 hours before starting the test. The solutions were distributed in the milk dispensers used previously. In each pen, the feeder was opened again as soon as the dispenser was filled with the solution. If needed, the dispensers were refilled during the tests so that dispensers were never empty during the 30-min tests. Solution refusals were weighed at the end of the 30-min tests and the dispensers were cleaned with hot water. Feed consumption was measured 4 hours after the feeders were opened (14:00). Solution and feed intake per pen were expressed in kg per kg of body weight.
Statistical analysis
Data were analyzed with SAS version 9.1.3 (Statistical Analysis Software; SAS Institute, Cary, NC, USA). Model residuals were checked for normal distribution using the Shapiro-Wilk test. If model residuals were not normally distributed, data were transformed for analyses. Data are presented as (untransformed) means ± SEMs.
Growth (i.e. average daily gain, ADG, g/d) before and after separation from the sow were analyzed using a MIXED procedure with formula (maltodextrin, control) as fixed effect and pen nested within formulas as random effect. Litter size at birth, included as a covariate in the initial model for ADG before separation from the sow, had no effect on any variables and was removed from the final model. Weight at separation from the sow was included as a covariate in the model for ADG after separation from the sow.
In total, 7 piglets were excluded from the analyses of the holeboard data because they showed extreme stress responses (1 maltodextrin piglet), refused to eat chocolate raisins even when offered by hand (1 pen of 2 maltodextrin piglets, 2 lactose piglets), have had extreme diarrhea at the start of the acquisition, thus not performing the task (1 lactose piglet), or died during the period of test (1 maltodextrin piglet).
Means of 4 consecutive trials were calculated, resulting in 7 and 4 trial blocks for acquisition and reversal phases, respectively. Data of the acquisition and reversal phases were analyzed using a MIXED procedure with formulas as fixed effect, block of trials as linear effect, and pen nested within formulas as random effect. Furthermore, the difference in performance during the transition phase was assessed using a MIXED procedure with formula, block and their interaction as fixed effect, and pen nested within formula as random effect. Sex, included as a fixed effect in the initial models, and its interaction with formula, had no effect on any variables and was removed from the final models.
Data from the single-solution consumption tests (solution and feed intake) were expressed in kg per kg of body weight. Data were analyzed using a MIXED procedure with formula (maltodextrin, lactose), solution (sucrose, sucralose), order of presentation (sucrose first, sucralose first) as fixed effects, weight at 17 weeks (before the start of the tests) as covariate, and pen nested with formula as random effect.
RESULTS
Spatial holeboard task Acquisition trials
Performance in the acquisition phase was significantly affected by trial blocks (Figure 2). WM and RM scores increased linearly, while WM and RM errors, trial duration and total number of visits decreased linearly over trial blocks ( P < 0.0001 for all). RM scores were significantly affected by formula c block interactions ( P = 0.0003), with piglets fed the maltodextrin-based formula having better RM scores than lactose group towards the end of the acquisition phase (blocks 5, 6 and 7). Formula had no effect on the other variables during the acquisition phase (P > 0.10 for all).
Transition phase
Piglets had lower RM scores ( P < 0.0001) and made more RM errors (P < 0.0001) during the first block of reversal trials than during the last block of acquisition trials (transition phase; Figure 3). WM scores and errors, however, remained unchanged (P > 0.10). Trial duration (P = 0.006) and latency to first baited visits (P = 0.0005) were significantly longer, and more visits were made (P < 0.0001) during the first block of reversal trials than during the last block of acquisition trials. During this transition
phase, piglets fed the maltodextrin-based formula tended to have better RM scores (P = 0.07), and to make fewer RM errors than lactose group ( P = 0.08). No effects of the formula c block interaction were found on any variables.
Reversal trials
After the drop in RM performance after the switch of configuration, RM scores (P < 0.0001) increased linearly, while the number of RM errors (P = 0.0005) decreased linearly over trial blocks during the reversal phase (Figure 2). The WM scores and WM errors were not affected by trial blocks (P > 0.10). Trial duration (P = 0.003), IVI (P = 0.01), total visits (P = 0.003), and latency to first baited visit (P = 0.04) decreased linearly over trial blocks during reversal phase. Formula or its interaction with blocks of trials had no effects on any of the variables during the reversal phase (P > 0.10 for all).
Single-solution consumption test
Irrespective of the formula, piglets drank more sucrose solution than sucralose solution during the test (P = 0.0002; Figure 4). Piglets consumed significantly less feed after the test with the (caloric) sucrose solution than after the test with the (non caloric) sucralose solution (P < 0.0001). The reduced feed intake of pigs tested with the sucrose solution resulted in relatively similar total energy intake (from solution and feed) between pigs tested with the sucrose solution and pigs tested with the sucralose solution (135 vs. 116 kcal/kg of BW). Formula and its interaction with solution had no effect on solution intake during the test (P > 0.10 for both), or feed intake after the test (P > 0.10 for both).
The results clearly indicates that consuming a maltodextrin-based formula, vs. a lactose-based formula, from 1 to 9 weeks of age, improves long-term memory (i.e. reference memory) in a spatial holeboard task, even weeks after the end of the intervention. Growth of the piglets all along the experiment was not affected by the type of carbohydrates contained in the milk formulas.
During the acquisition phase of the holeboard task, RM and WM scores improved, while errors, latency to first reward, and trial duration decreased linearly over time, indicating that young piglets were able to learn the task, as previously reported
{Antonides, et al. 2015;Antonides, et al. 2015;Clouard, et al. 2016;Gieling, et al. 2011 }. Piglets fed the maltodextrin-based formula showed, during acquisition, higher RM scores than piglets fed the lactose-based formula. Piglets fed the maltodextrin-based formula also tended to show higher RM scores and made fewer RM errors than the lactose group during the transition phase, i.e. during the switch to a ‘reversed’ configuration of baited buckets. The levels of performance found in both groups are within the ranges of performance reported in prior research using pigs of the same age {Antonides, et al. 2015; Antonides, et al. 2015; Clouard, et al. 2016 ; Gieling, et al. 201 1 }, suggesting that differences in RM performance were not caused by a reduced performance of the piglets fed the lactose-based formula.
A factor that might have affected the performance of the piglets in the holeboard task could be differences in stress levels between the two experimental groups. Stress is known to have a significant impact on spatial learning and memory {Conrad, et al. 2010 }, and the quality of carbohydrates (as measured by the glycemic index) consumed have been found to influence anxiety and stress in humans {Haghighatdoost, et al. 2016 } and animals. In our study, however, piglets have been extensively habituated to the task, the experimenters, and the apparatus before the start of the acquisition phase. After this phase of habituation, piglets selected for testing did not show any extreme stress responses, such as escape attempts, suggesting that differences in stress levels between groups were very unlikely to explain the effect of the formula on RM performance.
No effects of the formula were found on IVI and trial duration, during either the acquisition or transition phase. These results indicate that animals were equally motivated and physically able to perform the task {Gieling, et al. 201 1 ; van der Staay, et al. 2012 }, and that differences of performance were not due to motivational factors or locomotor problems. The absence of motivational bias for the sweet food rewards in the holeboard seems to be supported by data from the single-solution consumption tests conducted after the end of the holeboard test, in which the formula had no effect on the intake of sweet caloric (sucrose) or non-caloric (sucralose) solutions. As early life carbohydrates play an important role in the development of food preferences and the consumption of sweet, high-energy food later in life {Stephen, et al. 2012 }, we expected that the intake of formulas containing different carbohydrates in early life
would influence preference for sweet caloric or sweet non-caloric compounds later in life. Contrarily to our postulate, however, replacing lactose by maltodextrin in milk formulas did not alter long-term preferences (up to 8 wk after the end of the intervention) of piglets for sweet, caloric beverages; differences in motivation for the sweet, caloric food rewards used in the holeboard (chocolate raisins) were, therefore, very unlikely. As neither motivation, locomotion or stress seem to explain the differences of performance found in the holeboard task, it is safe to assume that the higher RM performance of the piglets fed the maltodextrin-based formula in the holeboard task reflects enhanced spatial long-term memory perse.
The effect of the formulas on long-term memory performance could be linked to differences in glucose availability in early life, as the brain appears to be sensitive to short-term variation in the availability of glucose (Grantham-McGregor 1987). Continuous glucose supply (to provide the brain with the required glucose for its high metabolism) is important for brain energy requirement but also its growth in animals, including pigs and humans {Vannucci, et al. 2000 }, and even more importantly in toddlers and young children than in adults (Bellisle, et al. 2004). It is well established that poor glucose supply or regulation is a risk factor for impaired cognitive development {Vannucci, et al. 2000 } and functioning (Philippou and Constantinou 2014). Lactose is a disaccharide of glucose and galactose compared to maltodextrin which comes from starch and made of only glucose units. Carbohydrate source in milk has been shown to modulate glucose regulation in humans (Innis and Novak 2014) which could suggest a difference in glucose availability for brain between piglets fed lactose or maltodextrin-based formulas. The type of carbohydrates (glucose-syrup DE 24, a starch derivative vs. lactose) in infant formula has been found to slightly modify metabolic post-prandial responses of formula-fed infants {Slupsky, 2017 }. Glycaemic load linked to food intake seems to influence cognitive functioning (Philippou and Constantinou 2014; Bellisle, et al. 2004; Ingwersen, et al. 2007; Micha, et al. 2011) but it remains to determine which variables of glucose metabolism are most strongly associated with cognition. It is thus possible that persistent changes in glucose metabolism in the early postnatal period shaped brain development and long term cognitive function of piglets in our study, possibly by impacting the supply of fuel needed for brain functioning.
Although the mechanisms underlying these effects remain unclear, carbohydrate sources in early life impacted the RM performance during the acquisition and transition phases, whereas WM seemed to be unaffected. This finding is consistent with prior research showing differential effects of early life factors (e.g. dietary iron deficiency, low birth weight) on WM and RM performance {Antonides, et al. 2015;Gieling, et al. 2012;Prickaerts, et al. 1999 }, which are two independent components of spatial memory {Niewoehner, et al. 2007 }. Although the hippocampus is thought to be required for both reference and working memory when it comes to spatial cognition {Floresco, et al. 1997;Steele, et al. 1999 }, lesion studies indicate differential effects of hippocampal alterations on RM and WM. Inactivation of the medial prefrontal cortex have been found to impair spatial WM, but not RM, of rats in a delayed alternation task. On the contrary, inactivation of the dorsal hippocampus increased RM errors {Yoon, et al. 2008 }. Lesions of the hippocampus, but not of the prefrontal cortex, also impaired spatial RM performance of rats in a water maze {Pothuizen, et al. 2004 }{Sloan, et al. 2006 }. That RM, but not WM, was affected by the early carbohydrate source in our study may indicate that hippocampal development, in particular, has been affected by the nutritional intervention. The duration of hippocampal growth in pigs is significantly longer than that of the cortex, i.e. 9 vs. 6 weeks {Conrad, et al. 2012 }. The critical windows for early nutritional influences is, therefore, larger for the development of the hippocampus than that of cortical structures, such as the prefrontal cortex, which may render the hippocampus more sensitive to early nutritional interventions.
Piglets took more time to finish the trial and to find the first reward, made more visits and more RM errors, and had lower RM scores during the first reversal trials (i.e. after the switch of configuration) than during the last acquisition trials, whatever the milk formula. This drop in performance illustrates the difficulty for the piglets to adapt to an unexpected change in baits location, as reported previously {Gieling, et al. 2012 }. Interestingly, RM performance of piglets fed the maltodextrin-based formula was improved not only during acquisition, but also during the transition phase (i.e. around the switch of configuration), suggesting that piglets fed the maltodextin-based formulas had better cognitive flexibility, that is a higher ability to cope with an unexpected change in the task {Gieling, et al. 2012 }{van der Staay, et al. 2012 }. Although the effect was not statistically significant (data not shown), visual analyse of
the data seems to support our postulate, with piglets fed the maltodextrin-based formula making (numerically) fewer visits and finding the first reward faster than the lactose group in the first block of reversal trials (Figure 2). Replicate studies on a larger set of animals are warranted to confirm or disprove this postulate.
In conclusion, piglets fed the maltodextrin-based formula showed improvement of spatial reference, /.e. long-term, memory in a holeboard task, even weeks after the end of the dietary intervention. Using maltodextrin in the infant formulas fed in early life did not affect growth or long-term preferences for sweet caloric or non-caloric beverages compared to a lactose-based formula. This is the first study showing, in the porcine model, that maltodextrin-based infant formulas are safe for growth and neurocognitive development.
Antonides, A., Schoonderwoerd, A. C., Nordquist, R. E., and van der Staay, F. J. (2015) Very low birth weight piglets show improved cognitive performance in the spatial cognitive holeboard task. Front Behav Neurosci 9, 43
Antonides, A., Schoonderwoerd, A. C., Scholz, G., Berg, B. M., Nordquist, R. E., and van der Staay, F. J. (2015) Pre-weaning dietary iron deficiency impairs spatial learning and memory in the cognitive holeboard task in piglets. Front Behav Neurosci 9, 291
Baldwin, B. A. (1976) Quantitative Studies on Taste Preference in Pigs. P Nutr Soc 35, 69-73
Benton, D., and a.i.s.b.l, I. E. (2008) The influence of children's diet on their cognition and behavior. Eur J Nutr 47 Suppl 3, 25-37
Bolton, J. L, and Bilbo, S. D. (2014) Developmental programming of brain and behavior by perinatal diet: focus on inflammatory mechanisms. Dialogues Clin Neurosci 16, 307-320
Caravas, J., and Wildman, D. E. (2014) A genetic perspective on glucose consumption in the cerebral cortex during human development. Diabetes Obes Metab 16 Suppl 1, 21-25
Clouard, C., Meunier-Salaun, M. C., and Val-Laillet, D. (2012) Food preferences and aversions in human health and nutrition: how can pigs help the biomedical research? Animal 6, 118-136
Clouard, C., Kemp, B., Val-Laillet, D., Gerrits, W. J., Bartels, A. C., and Bolhuis, J. E. (2016) Prenatal, but not early postnatal, exposure to a Western diet improves spatial memory of pigs later in life and is paired with changes in maternal prepartum blood lipid levels. FASEB J 30, 2466-2475
Cole, D. J. A., Duckwort.Je, and Holmes, W. (1967) Factors Affecting Voluntary Feed Intake in Pigs .1. Effect of Digestible Energy Content of Diet on Intake of Castrated Male Pigs Housed in Holding Pens and in Metabolism Crates. Anim Prod 9, 141-&
Conrad, C. D. (2010) A critical review of chronic stress effects on spatial learning and memory. Prog Neuropsychopharmacol Biol Psychiatry 34, 742-755
Conrad, M. S., Dilger, R. N., and Johnson, R. W. (2012) Brain growth of the domestic pig (Sus scrofa) from 2 to 24 weeks of age: a longitudinal MR! study. Developmental neuroscience 34, 291-298
Crisa, A. (2013) Milk carbohydrates and oligosaccharides. In Milk and dairy products in human nutrition: Production, composition and health (Park, Y. W., and Haenlein, G. F. W., eds) pp. 129-147, John Wiley & Sons, Ltd
CVB. (2008) CVB Table Booklet Feeding of Pigs: Feeding standards, feeding advices and nutritional values of feeding ingredients. CVB-series no 43, The Hague, The Netherlands
Dilger, R. N., and Johnson, R. W. (2010) Behavioral assessment of cognitive function using a translational neonatal piglet model. Brain Behav Immun 24, 11 Se ll 65
Dobbing, J., and Sands, J. (1979) Comparative aspects of the brain growth spurt. Early Hum Dev 3, 79-83
EFSA. (2014) Essential composition of infant and follow-on formulae. EFSA Journal 12
European Commission (2015) Commission Delegated Regulation (EU) 2016/127 of 25 September 2015 supplementing Regulation No 609/2013 of the European Parliament and the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding. In Official Journal of the European Union
Floresco, S. B., Seamans, J. K., and Phillips, A. G. (1997) Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks
with or without a delay. The Journal of neuroscience : the official journal of the Society for Neuroscience 17, 1880-1890
Gieling, E. T, Nordquist, R. E., and van der Staay, F. J. (2011) Assessing learning and memory in pigs. Anim Cogn 14, 151-173
Gieling, E. T., Park, S. Y., Nordquist, R. E., and van der Staay, F. J. (2012) Cognitive performance of low- and normal-birth-weight piglets in a spatial hole-board discrimination task. Pediatric research 71, 71-76
Glaser, D., Wanner, M., Tinti, J. M., and Nofre, C. (2000) Gustatory responses of pigs to various natural and artificial compounds known to be sweet in man. Food Chem 68, 375-385
Green Corkins, K., and Shurley, T. (2016) What's in the Bottle? A Review of Infant Formulas. Nutr Clin Pract
Haghighatdoost, F., Azadbakht, L, Keshteli, A. H., Feinle-Bisset, C., Daghaghzadeh, H., Afshar, H., Feizi, A., Esmaillzadeh, A., and Adibi, P. (2016) Glycemic index, glycemic load, and common psychological disorders. Am J Clin Nutr 103, 201-209
Heubi, J., Karasov, R., Reisinger, K., Blatter, M., Rosenberg, L, Vanderhoof, J., Darden, P. M., Safier, J., Martin, T., and Euler, A. R. (2000) Randomized multicenter trial documenting the efficacy and safety of a lactose-free and a lactose-containing formula for term infants. J Am Diet Assoc 100, 212-217
Hofman, D. L, van Buul, V. J., and Brouns, F. J. (2016) Nutrition, Health, and Regulatory Aspects of Digestible Maltodextrins. Critical reviews in food science and nutrition 56, 2091-2100
Kornum, B. R., and Knudsen, G. M. (2011) Cognitive testing of pigs (Sus scrofa) in translational biobehavioral research. Neurosci Biobehav Rev 35, 437-451
Krogh, U., Oksbjerg, N., Purup, S., Ramaekers, P., and Theil, P. K. (2016) Colostrum and milk production in multiparous sows fed supplementary arginine during gestation and lactation. J Anim Sci 94, 22-25
Lamport, D. J., Lawton, C. L, Mansfield, M. W., and Dye, L. (2009) Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review. Neurosci Biobehav Rev 33, 394-413
Langley-Evans, S. C. (2009) Nutritional programming of disease: unravelling the mechanism. J Anat 215, 36-51
Lind, N. M., Moustgaard, A., Jelsing, J., Vajta, G., Cumming, P., and Hansen, A. K. (2007) The use of pigs in neuroscience: modeling brain disorders. Neurosci Biobehav Rev 31, 728-751
Maldonado, J., Gil, A., Narbona, E., and Molina, J. A. (1998) Special formulas in infant nutrition: a review. Early Hum Dev 53 Suppl, S23-32
Moody, L., Chen, H., and Pan, Y. X. (2017) Early-Life Nutritional Programming of Cognition-The Fundamental Role of Epigenetic Mechanisms in Mediating the Relation between Early-Life Environment and Learning and Memory Process. Adv Nutr 8, 337-350
Murphy, M., and Mercer, J. G. (2013) Diet-regulated anxiety. International journal of endocrinology 2013, 701967
Niewoehner, B., Single, F. N., Hvalby, O., Jensen, \/., Meyer zum Alien Borgloh, S., Seeburg, P. H., Rawlins, J. N., Sprengel, R., and Bannerman, D. M. (2007) Impaired spatial working memory but spared spatial reference memory following functional loss of NMD A receptors in the dentate gyrus. Eur J Neurosci 25, 837-846 Patel, M. S., Srinivasan, M., and Laychock, S. G. (2009) Metabolic programming: Role of nutrition in the immediate postnatal life. J Inherit Metab Dis 32, 218-228
Pothuizen, H. H., Zhang, W. N., Jongen-Relo, A. L., Feldon, J., and Yee, B. K. (2004) Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur J Neurosci 19, 705-712
Prickaerts, J., Honig, W., Schmidt, B. H., and Blokland, A. (1999) Metrifonate improves working but not reference memory performance in a spatial cone field task. European journal of pharmacology 380, 61-65
Roura, E., Koopmans, S. J., Lalles, J. P., Le Huerou-Luron, I., de Jager, N., Schuurman, T, and Val-Laillet, D. (2016) Critical review evaluating the pig as a model for human nutritional physiology. Nutr Res Rev 29, 60-90
Sloan, H. L, Good, M., and Dunnett, S. B. (2006) Double dissociation between hippocampal and prefrontal lesions on an operant delayed matching task and a water maze reference memory task. Behav Brain Res 171, 116-126
Slupsky, C. M., He, X., Hernell, O., Andersson, Y., Rudolph, C., Lonnerdal, B., and West, C. E. (2017) Postprandial metabolic response of breast-fed infants and
infants fed lactose-free vs regular infant formula: A randomized controlled trial. Sci Rep 7, 3640
Souza, C. G., Moreira, J. D., Siqueira, I. R., Pereira, A. G., Rieger, D. K., Souza, D. O., Souza, T. M., Portela, L. V., and Perry, M. L. (2007) Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like beha vior. Life sciences 81, 198-203
Steele, R. J., and Morris, R. G. (1999) Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA- antagonist D-AP5. Hippocampus 9, 118-136
Stephen, A., Alles, M., de Graaf, C., Fleith, M., Hadjilucas, E., Isaacs, E.,
Maffeis, C., Zeinstra, G., Matthys, C., and Gil, A. (2012) The role and requirements of digestible dietary carbohydrates in infants and toddlers. Eur J Clin Nutr 66, 765-779 Tzanetakou, I. P., Mikhailidis, D. P., and Perrea, D. N. (2011) Nutrition During Pregnancy and the Effect of Carbohydrates on the Offspring's Metabolic Profile: In Search of the "Perfect Maternal Diet". Open Cardiovasc Med J 5, 103-109
van der Staay, F. J., Gieling, E. , Pinzon, N. E., Nordquist, R. E., and Ohl, F. (2012) The appetitively motivated "cognitive" holeboard: a family of complex spatial discrimination tasks for assessing learning and memory. Neurosci Biobehav Rev 36, 379-403
Vannucci, R. C., and Vannucci, S. J. (2000) Glucose metabolism in the developing brain. Semin Perinatol 24, 107-115
Yoon, T, Okada, J., Jung, M. W., and Kim, J. J. (2008) Prefrontal cortex and hippocampus subserve different components of working memory in rats. Learn Mem 15, 97-105
Claims
1. Use of a digestible maltodextrin having a dextrose equivalent (DE) of between 15 to 19 or a composition comprising thereof in the early childhood of a mammal for enhancing or improving cognition and/or stimulating brain development at adult age of said mammal.
2. The use according to claim 1 , wherein the cognitive performance is the cognitive flexibility of said mammal.
3. The use according to claim 1 , wherein the cognitive performance is the memory of said mammal.
4. The use according to claim 3, wherein the cognitive performance is the long term memory of said mammal.
5. The use according to claim 1 , wherein the maltodextrins stimulate the development of the area of the brain which responsible of spatial cognition.
6. The use according to claim 5, wherein the area responsible of spatial cognition is the hippocampus.
7. The use according to one of the claims 1 to 6, wherein the composition comprises 20 to 30 % of proteins, preferably vegetable proteins and/or animal proteins; 20 to 40% of maltodextrin and 20 to 40% of fat.
8. The use according to claims 1 to 7, wherein the composition is a formula-fed infant or a growing up milk.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1701309A FR3075001B1 (en) | 2017-12-14 | 2017-12-14 | USE OF MALTODEXTRINS TO IMPROVE COGNITION AND / OR STIMULATE BRAIN DEVELOPMENT |
FR17/01309 | 2017-12-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2019116329A1 true WO2019116329A1 (en) | 2019-06-20 |
WO2019116329A8 WO2019116329A8 (en) | 2020-01-30 |
Family
ID=61801996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2018/060083 WO2019116329A1 (en) | 2017-12-14 | 2018-12-14 | Use of maltodextrin for enhancing or improving cognition and/or stimulating brain development |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3075001B1 (en) |
WO (1) | WO2019116329A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2327733A1 (en) * | 1975-10-16 | 1977-05-13 | Lyall Neil | Powdered whole milk substitute - contg. whey or malto-dextrin as filler, hardened plant oil, sweetener and emulsifier |
FR2884422A1 (en) | 2005-04-18 | 2006-10-20 | Roquette Freres | ANTI-INFLAMMATORY COMPOSITION OF INTESTINES COMPRISING BRANCHED MALTODEXTRINS |
EP2422629A1 (en) | 2010-08-23 | 2012-02-29 | Abbott Laboratories | Methods for enhancing cognition and/or memory using maltodextrins |
US20140187514A1 (en) * | 2005-02-09 | 2014-07-03 | Vifor (International) Ag | Use Of Iron(III) Complex Compounds |
CN106615178A (en) * | 2017-01-13 | 2017-05-10 | 汉臣氏(沈阳)儿童制品有限公司 | Solid DHA (docosahexaenoic acid) algae oil beverage |
-
2017
- 2017-12-14 FR FR1701309A patent/FR3075001B1/en active Active
-
2018
- 2018-12-14 WO PCT/IB2018/060083 patent/WO2019116329A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2327733A1 (en) * | 1975-10-16 | 1977-05-13 | Lyall Neil | Powdered whole milk substitute - contg. whey or malto-dextrin as filler, hardened plant oil, sweetener and emulsifier |
US20140187514A1 (en) * | 2005-02-09 | 2014-07-03 | Vifor (International) Ag | Use Of Iron(III) Complex Compounds |
FR2884422A1 (en) | 2005-04-18 | 2006-10-20 | Roquette Freres | ANTI-INFLAMMATORY COMPOSITION OF INTESTINES COMPRISING BRANCHED MALTODEXTRINS |
US20080182821A1 (en) * | 2005-04-18 | 2008-07-31 | Roquette Freres | Anti-Inflammatory and/or Analgesic Composition For the Intestine Comprising Branched Maltodextrins |
EP2422629A1 (en) | 2010-08-23 | 2012-02-29 | Abbott Laboratories | Methods for enhancing cognition and/or memory using maltodextrins |
CN106615178A (en) * | 2017-01-13 | 2017-05-10 | 汉臣氏(沈阳)儿童制品有限公司 | Solid DHA (docosahexaenoic acid) algae oil beverage |
Non-Patent Citations (46)
Title |
---|
ANTONIDES, A.; SCHOONDERWOERD, A. C.; NORDQUIST, R. E.; VAN DER STAAY, F. J.: "Very low birth weight piglets show improved cognitive performance in the spatial cognitive holeboard task", FRONT BEHAV NEUROSCI, vol. 9, 2015, pages 43 |
ANTONIDES, A.; SCHOONDERWOERD, A. C.; SCHOLZ, G.; BERG, B. M.; NORDQUIST, R. E.; VAN DER STAAY, F. J.: "Pre-weaning dietary iron deficiency impairs spatial learning and memory in the cognitive holeboard task in piglets", RONT BEHAV NEUROSCI, vol. 9, 2015, pages 291 |
BALDWIN, B. A.: "Quantitative Studies on Taste Preference in Pigs", P NUTR SOC, vol. 35, 1976, pages 69 - 73 |
BENTON, D.; A.I.S.B.L, I. E.: "The influence of children's diet on their cognition and behavior", EUR J NUTR, vol. 47, 2008, pages 25 - 37, XP019628485 |
BOLTON, J. L.; BILBO, S. D.: "Dialogues Clin Neurosci", DEVELOPMENTAL PROGRAMMING OF BRAIN AND BEHAVIOR BY PERINATAL DIET: FOCUS ON INFLAMMATORY MECHANISMS, vol. 16, 2014, pages 307 - 320 |
CARAVAS, J.; WILDMAN, D. E.: "A genetic perspective on glucose consumption in the cerebral cortex during human development", DIABETES OBES METAB, vol. 1, 2014, pages 21 - 25 |
CLOUARD, C.; KEMP, B.; VAL-LAILLET, D.; GERRITS, W J.; BARTELS, A. C.; BOLHUIS, J. E.: "Prenatal, but not early postnatal, exposure to a Western diet improves spatial memory of pigs later in life and is paired with changes in maternal prepartum blood lipid levels", FASEB J, vol. 30, 2016, pages 2466 - 2475 |
CLOUARD, C.; MEUNIER-SALAUN, M. C.; VAL-LAILLET, D.: "Food preferences and aversions in human health and nutrition: how can pigs help the biomedical research", ANIMAL, vol. 6, 2012, pages 118 - 136 |
COLE, D. J. A.; DUCKWORT.JE; HOLMES, W: "Factors Affecting Voluntary Feed Intake in Pigs .1. Effect of Digestible Energy Content of Diet on Intake of Castrated Male Pigs Housed in Holding Pens and in Metabolism Crates", ANIM PROD, vol. 9, 1967, pages 141 |
CONRAD, C. D.: "Prog Neuropsychopharmacol Biol Psychiatry", A CRITICAL REVIEW OF CHRONIC STRESS EFFECTS ON SPATIAL LEARNING AND MEMORY, vol. 34, 2010, pages 742 - 755 |
CONRAD, M. S.; DILGER, R. N.; JOHNSON, R. W.: "Brain growth of the domestic pig (Sus scrofa) from 2 to 24 weeks of age: a longitudinal MRI study", DEVELOPMENTAL NEUROSCIENCE, vol. 34, 2012, pages 291 - 298 |
CRISA, A.: "In Milk and dairy products in human nutrition: Production, composition and health", 2013, JOHN WILEY & SONS, LTD, article "Milk carbohydrates and oligosaccharides", pages: 129 - 147 |
CVB: "CVB Table Booklet Feeding of Pigs: Feeding standards, feeding advices and nutritional values of feeding ingredients", CVB-SERIES NO 43, THE HAGUE, 2008 |
DILGER, R. N.; JOHNSON, R. W.: "Behavioral assessment of cognitive function using a translational neonatal piglet model", BRAIN BEHAV IMMUN, vol. 24, 2010, pages 1156 - 1165, XP027278948 |
DOBBING, J.; SANDS, J.: "Comparative aspects of the brain growth spurt", EARLY HUM DEV, vol. 3, 1979, pages 79 - 83, XP026198841, DOI: doi:10.1016/0378-3782(79)90022-7 |
EFSA: "Essential composition of infant and follow-on formulae", EFSA JOURNAL 12, 2014 |
FLORESCO, S. B.; SEAMANS, J. K.,; PHILLIPS, A. G.: "Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay", THE JOURNAL OF NEUROSCIENCE : THE OFFICIAL JOURNAL OF THE SOCIETY FOR NEUROSCIENCE, vol. 17, 1997, pages 1880 - 1890 |
GIELING, E. T.; NORDQUIST, R. E.; VAN DER STAAY, F. J.: "Assessing learning and memory in pigs", ANIM COGN, vol. 14, 2011, pages 151 - 173, XP019882498, DOI: doi:10.1007/s10071-010-0364-3 |
GIELING, E. T.; PARK, S. Y.; NORDQUIST, R. E.; VAN DER STAAY, F. J.: "Cognitive performance of low- and normal-birth-weight piglets in a spatial hole-board discrimination task", PEDIATRIC RESEARCH, vol. 71, 2012, pages 71 - 76 |
GLASER, D.; WANNER, M.; TINTI, J. M.; NOFRE, C.: "Gustatory responses of pigs to various natural and artificial compounds known to be sweet in man", FOOD CHEM, vol. 68, 2000, pages 375 - 385, XP000884165, DOI: doi:10.1016/S0308-8146(99)00212-5 |
GREEN CORKINS, K.; SHURLEY, T.: "What's in the Bottle? A Review of Infant Formulas", NUTR CLIN PRACT, 2016 |
HAGHIGHATDOOST, F.; AZADBAKHT, L.; KESHTELI, A. H.; FEINLE-BISSET, C.; DAGHAGHZADEH, H.; AFSHAR, H.; FEIZI, A.; ESMAILLZADEH, A.;: "Glycemic index, glycemic load, and common psychological disorders", AM J CLIN NUTR, vol. 103, 2016, pages 201 - 209 |
HEUBI, J.; KARASOV, R.; REISINGER, K.; BLATTER, M.; ROSENBERG, L.; VANDERHOOF, J.; DARDEN, P. M.; SAFIER, J.; MARTIN, T.; EULER, A: "Randomized multicenter trial documenting the efficacy and safety of a lactose-free and a lactose-containing formula for term infants", J AM DIET ASSOC, vol. 100, 2000, pages 212 - 217 |
HOFMAN, D. L.; VAN BUUL, V. J.; BROUNS, F. J.: "Nutrition, Health, and Regulatory Aspects of Digestible Maltodextrins", CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, vol. 56, 2016, pages 2091 - 2100 |
KORNUM, B. R.; KNUDSEN, G. M.: "Cognitive testing of pigs (Sus scrofa) in translational biobehavioral research", NEUROSCI BIOBEHAV REV, vol. 35, 2011, pages 437 - 451, XP027552994 |
KROGH, U.; OKSBJERG, N.; PURUP, S.; RAMAEKERS, P.; THEIL, P. K.: "Colostrum and milk production in multiparous sows fed supplementary arginine during gestation and lactation", J ANIM SCI, vol. 94, 2016, pages 22 - 25 |
LAMPORT, D. J.; LAWTON, C. L.; MANSFIELD, M. W,; DYE, L.: "Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review", NEUROSCI BIOBEHAV REV, vol. 33, 2009, pages 394 - 413, XP025913467, DOI: doi:10.1016/j.neubiorev.2008.10.008 |
LANGLEY-EVANS, S. C.: "Nutritional programming of disease: unravelling the mechanism", J ANAT, vol. 215, 2009, pages 36 - 51 |
LIND, N. M.; MOUSTGAARD, A.,; JELSING, J.; VAJTA, G.; CUMMING, P.; HANSEN, A. K.: "The use of pigs in neuroscience: modeling brain disorders", NEUROSCI BIOBEHAV REV, vol. 31, 2007, pages 728 - 751, XP022060939, DOI: doi:10.1016/j.neubiorev.2007.02.003 |
MALDONADO, J.; GIL, A.; NARBONA, E.; MOLINA, J. A.: "Special formulas in infant nutrition: a review", EARLY HUM DEV 53 SUPPL, 1998, pages S23 - 32 |
MOODY, L.; CHEN, H.; PAN, Y. X.: "Early-Life Nutritional Programming of Cognition-The Fundamental Role of Epigenetic Mechanisms in Mediating the Relation between Early-Life Environment and Learning and Memory Process", ADV NUTR, vol. 8, 2017, pages 337 - 350 |
MURPHY, M.; MERCER, J. G.: "Diet-regulated anxiety", INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, pages 701967 |
NIEWOEHNER, B.; SINGLE, F. N.; HVALBY, O.; JENSEN, V.; MEYER ZUM ALTEN BORGLOH, S.; SEEBURG, P. H.; RAWLINS, J. N.; SPRENGEL, R.;: "Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus", EUR J NEUROSCI, vol. 25, 2007, pages 837 - 846 |
PATEL, M. S.; SRINIVASAN, M.; LAYCHOCK, S. G.: "Metabolic programming: Role of nutrition in the immediate postnatal life", J INHERIT METAB DIS, vol. 32, 2009, pages 218 - 228, XP019671019 |
POTHUIZEN, H. H.; ZHANG, W N.; JONGEN-RELO, A. L.; FELDON, J.; YEE, B. K.: "Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory", EUR J NEUROSCI, vol. 19, 2004, pages 705 - 712 |
PRICKAERTS, J.; HONIG, W, SCHMIDT, B. H.; BLOKLAND, A.: "Metrifonate improves working but not reference memory performance in a spatial cone field task", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 380, 1999, pages 61 - 65 |
ROURA, E.; KOOPMANS, S. J.; LALLES, J. P.; LE HUEROU-LURON, I.; DE JAGER, N.; SCHUURMAN, T.; VAL-LAILLET, D.: "Critical review evaluating the pig as a model for human nutritional physiology", NUTR RES REV, vol. 29, 2016, pages 60 - 90 |
SLOAN, H. L.; GOOD, M.; DUNNETT, S. B.: "Double dissociation between hippocampal and prefrontal lesions on an operant delayed matching task and a water maze reference memory task", BEHAV BRAIN RES, vol. 171, 2006, pages 116 - 126, XP025031748, DOI: doi:10.1016/j.bbr.2006.03.030 |
SLUPSKY, C. M.; HE, X.; HERNELL, O.; ANDERSSON, Y.; RUDOLPH, C.; LONNERDAL, B.; WEST, C. E.: "Postprandial metabolic response of breast-fed infants and infants fed lactose-free vs regular infant formula: A randomized controlled trial", SCI REP, vol. 7, 2017, pages 3640 |
SOUZA, C. G.; MOREIRA, J. D.; SIQUEIRA, I. R.; PEREIRA, A. G.; RIEGER, D. K.; SOUZA, D. O.; SOUZA, T. M.; PORTELA, L. V.; PERRY, M: "Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior", LIFE SCIENCES, vol. 81, 2007, pages 198 - 203, XP022133087, DOI: doi:10.1016/j.lfs.2007.05.001 |
STEELE, R. J.; MORRIS, R. G.: "Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5", HIPPOCAMPUS, vol. 9, 1999, pages 118 - 136 |
STEPHEN, A.; ALLES, M.; DE GRAAF, C.; FLEITH, M.; HADJILUCAS, E.; ISAACS, E.; MAFFEIS, C.; ZEINSTRA, G.; MATTHYS, C.; GIL, A.: "The role and requirements of digestible dietary carbohydrates in infants and toddlers", EUR J CLIN NUTR, vol. 66, 2012, pages 765 - 779 |
TZANETAKOU, I. P.; MIKHAILIDIS, D. P.; PERREA, D. N.: "Nutrition During Pregnancy and the Effect of Carbohydrates on the Offspring's Metabolic Profile: In Search of the ''Perfect Maternal Diet''", OPEN CARDIOVASC MED J, vol. 5, 2011, pages 103 - 109 |
VAN DER STAAY, F. J.; GIELING, E. T.; PINZON, N. E.; NORDQUIST, R. E.; OHL, F.: "The appetitively motivated ''cognitive'' holeboard: a family of complex spatial discrimination tasks for assessing learning and memory", NEUROSCI BIOBEHAV REV, vol. 36, 2012, pages 379 - 403, XP028119116, DOI: doi:10.1016/j.neubiorev.2011.07.008 |
VANNUCCI, R. C.; VANNUCCI, S. J.: "Glucose metabolism in the developing brain", SEMIN PERINATOL, vol. 24, 2000, pages 107 - 115, XP009026677, DOI: doi:10.1053/sp.2000.6361 |
YOON, T.; OKADA, J.; JUNG, M. W.; KIM, J. J.: "Prefrontal cortex and hippocampus subserve different components of working memory in rats", LEARN MEM, vol. 15, 2008, pages 97 - 105 |
Also Published As
Publication number | Publication date |
---|---|
FR3075001A1 (en) | 2019-06-21 |
FR3075001B1 (en) | 2021-09-10 |
WO2019116329A8 (en) | 2020-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Oostindjer et al. | Prenatal flavor exposure affects growth, health and behavior of newly weaned piglets | |
Val-Laillet et al. | A maternal Western diet during gestation and lactation modifies offspring's microbiota activity, blood lipid levels, cognitive responses, and hippocampal neurogenesis in Yucatan pigs | |
Odle et al. | The suckling piglet as an agrimedical model for the study of pediatric nutrition and metabolism | |
Sullivan et al. | Infant dietary experience and acceptance of solid foods | |
Clouard et al. | Food preferences and aversions in human health and nutrition: how can pigs help the biomedical research? | |
Noble et al. | Lactational performance of first-parity transgenic gilts expressing bovine alpha-lactalbumin in their milk | |
Brooks et al. | Factors affecting the voluntary feed intake of the weaned pig | |
US20070110880A1 (en) | Hypoallergenic animal food | |
Gordon et al. | Fat excretion of premature infants: I. Effect on fecal fat of decreasing fat intake | |
MX2008007517A (en) | Compositions and methods for preserving brain function. | |
Harrison et al. | Nutritional considerations section II | |
MX2011010454A (en) | Improvement in promotion of healthy catch-up growth. | |
Quigley et al. | Effects of colostrum and milk replacer feeding rates on intake, growth, and digestibility in calves | |
Caballero Valcárcel et al. | Iron bioavailability of four iron sources used to fortify infant cereals, using anemic weaning pigs as a model | |
US11872238B2 (en) | Nutritional composition for use to enhance attention and/or reduce impulsivity | |
Clouard et al. | A milk formula containing maltodextrin, vs. lactose, as main carbohydrate source, improves cognitive performance of piglets in a spatial task | |
US20140377404A1 (en) | Use of specific carbohydrate systems during pregnancy for effecting the offspring | |
Figueroa et al. | Flavour preferences conditioned by protein solutions in post-weaning pigs | |
Oberleas et al. | Trace elements and behavior | |
WO2019116329A1 (en) | Use of maltodextrin for enhancing or improving cognition and/or stimulating brain development | |
JP2011063552A (en) | Physical activity promoter | |
AU2014314537B2 (en) | Lactoferrin and memory and learning speed in children | |
DiBattista | Conditioned taste avoidance induced by lactose ingestion in adult rats | |
Buddington et al. | Organ growth and intestinal functions of preterm pigs fed low and high protein formulas with or without supplemental leucine or hydroxymethylbutyrate as growth promoters | |
JP6071988B2 (en) | Physical activity promoter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18836521 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18836521 Country of ref document: EP Kind code of ref document: A1 |